In the evolving landscape of medical aesthetics, Elasticity Boosters have transitioned from simple topical creams to complex bio-active injectables and advanced serum systems. Skin elasticity (turgor) is governed by the intricate architecture of the extracellular matrix (ECM), primarily composed of collagen, elastin, and glycosaminoglycans.
Polydeoxyribonucleotide (PDRN), derived from salmon DNA, is a game-changer in cellular repair, stimulating fibroblast activity to naturally increase elastin production from within.
Dimethylaminoethanol (DMAE) acts as a precursor to acetylcholine, increasing muscle tone and providing an immediate "lifting" effect for sagging skin tissue.
Nicotinamide Adenine Dinucleotide is essential for cellular energy. By integrating NAD+ into skin boosters, we facilitate mitochondrial health, prolonging the lifespan of skin cells.
Founded in 2009, Jiangsu Menuka Medical Co., Ltd. is a leading innovator in the field of medical skincare and dermatological solutions. As a modern enterprise integrating R&D, intelligent manufacturing, clinical application, and global distribution, Menuka Medical is dedicated to advancing the future of professional skincare through science, safety, and innovation.
With years of expertise in dermatology and post-procedure skincare, Menuka Medical continuously develops advanced formulations and functional skincare products supported by patented technologies, clinical validation, and strict quality standards. Our products are specially designed to address sensitive skin conditions, aesthetic recovery, and professional dermatological care.
At Menuka Medical, we believe skincare is more than a daily routine — it is a professional solution that enhances skin health, confidence, and quality of life. Our products focus on Clinical efficacy, Safety, Post-procedure recovery, and Scientific innovation.
Our facility in Jiangsu serves as a hub for precision engineering in cosmetics. Leveraging China's robust supply chain, we provide unparalleled speed-to-market for global brands.
Navigating the regulatory landscape of the EU (CE/CPNP), USA (FDA), and Southeast Asia (ASEAN) is complex. We provide full documentation support, including MSDS, COA, and Stability Testing, ensuring your products meet local legal standards for seamless entry.
By centralizing R&D and manufacturing in Jiangsu, we reduce lead times by 30% compared to European counterparts. Our proximity to premium raw material suppliers allows for cost-efficient production without compromising on "Medical Grade" quality.
Industry data suggests a shift toward "Bio-Hacking" skincare. Consumers are no longer satisfied with surface hydration; they demand Deep Tissue Remodeling. Our R&D is currently focusing on Exosomes and Cross-linked Hyaluronic Acid combinations to provide long-lasting scaffolding for the skin.
A1: Our formulas utilize medical-grade active ingredients like PDRN and NAD+ at clinical concentrations. Unlike cosmetic-grade products, ours are designed for transdermal delivery or post-laser recovery, ensuring visible structural changes in the skin.
A2: Yes. We offer end-to-end OEM/ODM services, from custom formulation to packaging design and regulatory filing support for global distribution.
A3: Every batch undergoes rigorous accelerated aging tests and thermal film shrinking packaging to ensure integrity during long-distance maritime or air freight.
As we continue expanding our global presence, Jiangsu Menuka Medical Co., Ltd. welcomes distributors, medical partners, and skincare professionals worldwide to collaborate with us. Together, we are shaping the future of dermatology skincare through science, innovation, and professional excellence.
Menuka Medical
